Audris Huang

This inventor holds 26 USPTO granted patents and 6 published patent applications and 16 EPO patents, primarily in Cancer Treatment. Top assignees: Bristol-Myers Squibb Compnay, Flexus Biosciences, Inc., Syngene International Limited. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Audris Huang. Retrieved from https://idiyas.com/inventor/audris-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 6)

% Patents Active = 100.0

EPO Patents = 16 (Patent Applications = 19)

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 69(Granted Patents)

Location History:

Princeton, NJ (US) (2014 - 2022)
New Hope, PA (US) (2014 - 2023)

Company Filing History:

22 out of 3,745

Bristol-Myers Squibb Compnay

patents

5 out of 8

Flexus Biosciences, Inc.

patents

4 out of 7

Syngene International Limited

patents

4. 1 out of 41

Bristol Meyers Squibb Company

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

IDO Inhibitors

Oxoisoindoline Compounds

Cyclic Dinucleotides

Immunoregulatory Agents

Cancer Treatment

Pyridinyl Compounds

CYP17 Modulators

Bicyclic Heteroaryl Compounds

Sulfonamide Compounds

Benzimidazole Compounds

Azaindazole Compounds

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570671 - SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER (2026-03-10),

2. 11718601 - Pyridinyl substituted oxoisoindoline compounds (2023-08-08),

3. 11548870 - Compounds useful as inhibitors of helios protein (2023-01-10),

4. 11427610 - Cyclic dinucleotides as anticancer agents (2022-08-30),

5. 11337970 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2022-05-24),

6. 11066392 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2021-07-20),

7. 10633342 - Inhibitors of indoleamine 2,3-dioxygenase and methods of their use (2020-04-28),

8. 10533014 - Immunoregulatory agents (2020-01-14),

9. 10399933 - Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer (2019-09-03),

10. 10399932 - Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer (2019-09-03),

11. 10206893 - Immunoregulatory agents (2019-02-19),

12. 10167254 - IDO inhibitors (2019-01-01),

13. 10106546 - Immunoregulatory agents (2018-10-23),

14. 9895330 - IDO inhibitors (2018-02-20),

15. 9790169 - IDO inhibitors (2017-10-17),

Title: Inventor Audris Huang: Pioneering Innovations in New Hope

Introduction: Audris Huang is a visionary inventor based in New Hope, PA, known for her groundbreaking contributions to various industries.

Latest Patents: Audris Huang holds several patents in the fields of biotechnology, renewable energy, and consumer electronics, showcasing her diverse range of expertise.

Career Highlights: With over two decades of experience, Audris has led numerous research projects that have resulted in cutting-edge inventions, earning her recognition as a trailblazer in the innovation landscape.

Collaborations: Throughout her career, Audris has collaborated with top research institutions, leading companies, and universities to further develop and commercialize her inventions, solidifying her reputation as a collaborative and forward-thinking inventor.

Conclusion: Audris Huang's passion for innovation and her relentless drive to push the boundaries of technology continue to inspire the next generation of inventors and shape the future of various industries.

Profile summary based on public USPTO records.